Paul Lountzis
Lountzis Asset Management
Lountzis Asset Management Portfolio 13F
Paul Lountzis Holdings Activity
- Portfolio value:
- $174.98M≈ (+$14M≈)
- Previous value:
- $160.57M≈
- # of changes:
- 81
- New positions:
- 0
- Reported for:
- 31 Dec 2021 (Q4)
- Latest filing date:
- 26 Jan 2022
Lountzis Asset Management has disclosed a total of 81 changes to the portfolio in the (2021 Q4) SEC report(s): increased the number of shares of 1, decreased the number of shares of 10 and completely sold out 70 position(s).
What stocks did Paul Lountzis buy in 2021 Q4?
During 2021 Q4 Paul Lountzis has bought (BRK-B) Berkshire Hathaway Inc (added shares +0.01%).
81 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Berkshire Hathaway Inc
|
+0.01%
|
+19
|
152,275
|
+0%
|
$299.00
|
+71.37%($512.40)
|
26.02%
|
2020 Q2
|
≈ 1.75 years
|
|
|
|
Applied Materials Inc
|
-0.02%
|
-20
|
110,499
|
-0%
|
$157.36
|
+226.61%($513.96)
|
9.94%
|
2020 Q4
|
≈ 1.25 years
|
|
|
|
Alphabet Inc, CL-A
|
-0.09%
|
-40
|
45,720
|
-0%
|
$144.85
|
+158.61%($374.60)
|
3.78%
|
2020 Q2
|
≈ 1.75 years
|
|
|
|
Laboratory Corp of America Holdings
|
-0.17%
|
-18
|
10,294
|
-0%
|
$314.21
|
-1.56%($309.31)
|
1.85%
|
2020 Q2
|
≈ 1.75 years
|
|
|
|
Progressive Corp
|
-0.22%
|
-206
|
93,307
|
-0.01%
|
$102.65
|
+104.62%($210.04)
|
5.47%
|
2020 Q2
|
≈ 1.75 years
|
|
|
|
Zoetis Inc
|
-0.22%
|
-115
|
51,771
|
-0.02%
|
$244.03
|
-68.21%($77.57)
|
7.22%
|
2020 Q2
|
≈ 1.75 years
|
|
|
|
UnitedHealth Group Incorporated
|
-0.31%
|
-38
|
12,108
|
-0.01%
|
$502.14
|
-17.08%($416.40)
|
3.47%
|
2020 Q2
|
≈ 1.75 years
|
|
|
|
Brown & Brown Inc
|
-0.37%
|
-562
|
150,354
|
-0.02%
|
$70.28
|
+1.83%($71.56)
|
6.04%
|
2020 Q2
|
≈ 1.75 years
|
|
|
|
Martin Marietta Materials Inc
|
-0.45%
|
-58
|
12,743
|
-0.02%
|
$440.52
|
+23.55%($544.26)
|
3.21%
|
2020 Q2
|
≈ 1.75 years
|
|
|
|
Wells Fargo & Company
|
-3.76%
|
-9,792
|
250,964
|
-0.29%
|
$47.98
|
+81.73%($87.20)
|
6.88%
|
2020 Q2
|
≈ 1.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.